Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aurora Cannabis | 6-K: Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors
Aurora Cannabis | 6-K: Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence
Aurora Cannabis | 6-K: Material Change Report
Aurora Cannabis | 6-K: Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility
Aurora Cannabis | 6-K: Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility
Aurora Cannabis | 6-K: Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 40-F: FY2024 Annual Report
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
No Data